The MHRA’s new resources are intended to help individuals make better-informed decisions about the digital mental health ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today updated product information for healthcare ...
Agency updates guidance after increase in reports of condition to the yellow card scheme ...
The UK’s medicines regulator has warned that patients using weight-loss drugs known as GLP-1s face a small risk of developing ...
BRITISH health chiefs have confirmed fat jabs could trigger a deadly, organ-destroying side effect. GLP-1 injections like ...
Symptoms to look out for include severe pain in the stomach and back which does not go away.
The Medicines and Healthcare products Regulatory Agency has updated its guidance on weight loss drugs over a rare ...
MHRA issues warning after seizing illegal fillers worth up to £4m - MHRA warned unlicensed fillers could ‘put your health at ...
GlobalData on MSN
UK’s MHRA gives high-dose Wegovy the go-ahead in obesity
The UK’s MHRA is the first regulatory agency to approve the high-dose Wegovy regimen.
Novo Nordisk’s Wegovy (semaglutide injection) has received a new approval from the Medicines and Healthcare products Regulatory Agency (MHRA), this time for a 7.2mg dose designed for the weight ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) today revealed it has formally begun its year as chair of the Access Consortium for 2026, marking a new phase of international ...
Updated product information for healthcare professionals and patients regarding the small risk of severe acute pancreatitis in patients taking GLP-1s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results